Official Title
REassessement After Hospitalization for Sars-COV-2 Infection : Standardized Assessment of Sequelae and Comorbidities 3 to 6 Months After Hospitalization
Brief Summary

Currently, the sequelae and short-term medical and psychological impact of the sars-cov-2 infection ("CoVID-19") remain poorly described. The clinical and functional sequelae that may persist after acute sars-cov-2 ("CoVID-19") infection are essential to explore, in order to ensure the best possible follow-up of patients after discharge from hospital.

Detailed Description

Since sars-cov-2 ("CoVID-19") is a newly defined infection, its sequelae and short-term
medical and psychological impact remain poorly described.The clinical and functional sequelae
that may persist after acute sars-cov-2 ("CoVID-19") infection are essential to explore, in
order to ensure the best possible follow-up of patients after discharge from hospital.

Indeed, some patients may develop chronic respiratory failure, pulmonary fibrosis, or other
comorbidities including cardiovascular or metabolic diseases. The psychological impact is
also essential to assess. The sequelae and comorbidities of patients could also vary
depending on the severity of the initial acute involvement.

Investigators propose to explore the sequelae of patients who have been hospitalized for
acute sars-cov-2 infection, between 3 to 6 months after discharge from hospital, by
characterizing the incidence of chronic respiratory failure and fibrosis, as well as of
various comorbidities such as cardiovascular, metabolic, and psychological diseases.

Terminated
SARS-COV2

Other: assessment of the sequelae after hospitalization for Sars-COV-2

the incidence of chronic respiratory failure and fibrosis, as well as of comorbidities including cardiovascular, metabolic, renal, hepatic, neurological, and psychological diseases

Eligibility Criteria

Inclusion Criteria:

- patient who was hospitalized within 3 to 6 months for a sars-CoV infection

Exclusion Criteria:

- Absence of signed informed consent

- pregnancy or breastfeeding

- patient under guardianship or curatorship

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

University hospital of Montpellier
Montpellier, France

University Hospital, Montpellier
NCT Number
Keywords
comorbidities
SARS-CoV2
sequelae
patient outcome assessment
COVID19
Quality of Life